Your cart is currently empty!
Proviron(Mesterolone)-50mg
Proviron 50mg (Mesterolone) – Product Description Proviron 50mg delivers a potent dose of Mesterolone, a non-aromatizing oral androgen often used to support hormone balance, boost libido, and enhance physique definition. With a stronger 50mg formulation, this version is ideal for experienced users or those seeking a simplified dosing schedule. Key Features: Active Compound: Mesterolone Dosage: 50mg per tablet Form: Oral non-anabolic androgen Half-Life: 12–13 hours Class: DHT derivative, anti-estrogenic agent Core Benefits: Increases free testosterone by binding to SHBG (Sex Hormone Binding Globulin) Improves muscle hardness, vascularity, and definition Helps control estrogenic side effects like water retention and gyno when…
Description
Proviron 50mg (Mesterolone) – Product Description
Proviron 50mg delivers a potent dose of Mesterolone, a non-aromatizing oral androgen often used to support hormone balance, boost libido, and enhance physique definition. With a stronger 50mg formulation, this version is ideal for experienced users or those seeking a simplified dosing schedule.
Key Features:
-
Active Compound: Mesterolone
-
Dosage: 50mg per tablet
-
Form: Oral non-anabolic androgen
-
Half-Life: 12–13 hours
-
Class: DHT derivative, anti-estrogenic agent
Core Benefits:
-
Increases free testosterone by binding to SHBG (Sex Hormone Binding Globulin)
-
Improves muscle hardness, vascularity, and definition
-
Helps control estrogenic side effects like water retention and gyno when stacked
-
May improve libido, mood, and sexual function
-
No estrogen conversion, zero risk of aromatization
Suggested Use:
-
Men: 50–100mg per day (can be taken once or split in two doses)
-
Cycle Use: Common in cutting cycles or to enhance the effectiveness of other anabolic agents
-
Women: Not typically recommended due to androgenic potency
-
Cycle Duration: 6–12 weeks, depending on goals and stack
Additional information
| Quantity | 1424-00-6 100pcs |
|---|

Reviews
There are no reviews yet.